Science

Line blot for myositis shows high agreement with biopsy

A multiparameter EUROLINE blot for detection of myositis-related autoantibodies showed a high agreement with muscle biopsy results in patients with idiopathic inflammatory myopathies (IIM), suggesting it can be used as a first-line diagnostic tool in the diagnostic workflow. The recently published study was performed as part of a collaboration between scientists from EUROIMMUN Brazil and

Science

Role of Epstein-Barr virus in multiple sclerosis

The frequency of intrathecal antibody production to Epstein-Barr virus (EBV) in multiple sclerosis (MS) patients is surprisingly low compared to that of other microbial agents. This was shown in a collaborative study between EUROIMMUN and scientists at Charité Universitätsmedizin Berlin. The finding is intriguing given the strong link between EBV and MS. EBV is presumed

Products

Revvity’s EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay

Press release, March 3rd 2025 Revvity, Inc. (NYSE: RVTY), today announced the launch of EUROIMMUN’s CE-marked Anti-Measles Virus ELISA 2.0 (IgG) to support the diagnosis of a measles virus infection or to determine the immune status against measles virus. EUROIMMUN’s Anti-Measles Virus ELISA 2.0 (IgG) is the first of several assays in development expanding EUROIMMUN’s

Science

SARS-CoV-2 vaccine safety in an autoimmunity-prone population

A new study has shown that mRNA vaccines against SARS-CoV-2 do not induce short-term worsening of autoimmunity in patients with autoimmune liver diseases (AILD). The collaborative study between EUROIMMUN and researchers at the Epatocentro Ticino, Lugano and other institutes and clinics in Switzerland was published recently in the Journal of Autoimmunity. The mRNA vaccines against

Scroll to Top